Hansoh Pharmaceutical Group Co Ltd 03692
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 03692 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- HKD 16.80
- Day Range
- HKD 16.76–17.26
- 52-Week Range
- HKD 9.41–17.26
- Bid/Ask
- HKD 17.24 / HKD 17.24
- Market Cap
- HKD 102.35 Bil
- Volume/Avg
- 5.2 Mil / 5.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 29.01
- Price/Sales
- 8.43
- Dividend Yield (Trailing)
- 0.72%
- Dividend Yield (Forward)
- 0.72%
- Total Yield
- 0.72%
Company Profile
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 9,123
- Website
- https://www.hspharm.com
Comparables
Valuation
|
Metric
|
03692
|
02552
|
RGC
|
|---|---|---|---|
Price/Earnings (Normalized) | 29.01 | — | — |
Price/Book Value | 3.26 | 13.98 | 6.00 |
Price/Sales | 8.43 | 18.32 | — |
Price/Cash Flow | 31.71 | 1.58 | — |
Price/Earnings
03692
02552
RGC
Financial Strength
|
Metric
|
03692
|
02552
|
RGC
|
|---|---|---|---|
Quick Ratio | 3.66 | 3.53 | 19.15 |
Current Ratio | 3.74 | 3.80 | 19.15 |
Interest Coverage | 41.01 | −36.00 | — |
Quick Ratio
03692
02552
RGC
Profitability
|
Metric
|
03692
|
02552
|
RGC
|
|---|---|---|---|
Return on Assets (Normalized) | 8.91% | −19.18% | −33.37% |
Return on Equity (Normalized) | 11.95% | −181.50% | −35.23% |
Return on Invested Capital (Normalized) | 8.47% | −48.36% | −34.27% |
Return on Assets
03692
02552
RGC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Vtcjzlkhs | Ntpvvt | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Stcytzxky | Qvsy | $68.9 Bil | |
HLN
| Haleon PLC ADR | Xmvmvggb | Kwm | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Hvvwslw | Fmgh | $14.8 Bil | |
VTRS
| Viatris Inc | Kmldflvh | Pvfxm | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cgnztkj | Bjlc | $11.9 Bil | |
CTLT
| Catalent Inc | Fpcmwbzh | Ygntw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ydpwztqdd | Mfqcm | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Qcvlgkqky | Lmnq | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xmtfrct | Yhpxpz | $3.5 Bil |